Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $687.14 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $201.92 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.46 | 1 | $0 (2023) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $100.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $57.21 | 2 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.80 | 1 | $0 (2019) |
| Boston Scientific Corporation | $22.75 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.95 | 3 | GlaxoSmithKline, LLC. ($74.20) |
| 2023 | $130.46 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($130.46) |
| 2022 | $36.45 | 1 | GlaxoSmithKline, LLC. ($36.45) |
| 2019 | $142.21 | 4 | GlaxoSmithKline, LLC. ($56.41) |
| 2018 | $181.07 | 3 | Genentech USA, Inc. ($125.00) |
| 2017 | $100.00 | 1 | Teva Pharmaceuticals USA, Inc. ($100.00) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.86 | General |
| 10/08/2024 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: EkoSonic_PI | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $34.34 | General |
| 06/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $130.46 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $36.45 | General |
| 10/23/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $32.34 | General |
| 10/22/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $49.80 | General |
| 10/22/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Respiratory | ||||||
| 10/09/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/08/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Respiratory | ||||||
| 10/06/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2017 | Teva Pharmaceuticals USA, Inc. | RESLIZUMAB (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 15 | $17,248 | $1,825 |
| 2021 | 1 | 15 | 19 | $12,445 | $1,284 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $17,248 | $1,825 | 10.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 19 | $12,445 | $1,284 | 10.3% |
About Dr. David Prezant, MD
Dr. David Prezant, MD is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184713489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Prezant, MD has received a total of $687.14 in payments from pharmaceutical and medical device companies, with $96.95 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($687.14).
As a Medicare-enrolled provider, Prezant has provided services to 30 Medicare beneficiaries, totaling 34 services with total Medicare billing of $3,109. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Bronx, NY
- Active Since 10/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1184713489
Products in Payments
- OFEV (Drug) $130.46
- RESLIZUMAB (Drug) $100.00
- TRELEGY ELLIPTA (Drug) $58.93
- FASENRA (Drug) $57.21
- EkoSonic (Device) $22.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Dr. Samuel Deleon, M.d, M.D
Pulmonary Disease — Payments: $11,703
Dr. Manuel Cabrera, Md, MD
Pulmonary Disease — Payments: $7,790